Two-Year Outcomes Following Transseptal TMVR in the HighLife Feasibility Study: Hemodynamic Performance and Clinical Results
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Abbott; Bayer AG; Corvia Medical